ABGABEVORRICHTUNG
Patent europeic · EP2847096 · Stritgà
Inscripziun en il register
- Numer da publicaziun
- EP2847096
- Numer da la dumonda
- EP13721757
- Gener
- Patent europeic cun effect per la Svizra ed il Liechtenstein
- Status
- Stritgà
- Scrittira da patent
- Concedì
- Annunzià
- 09-05-2013
- Publitgà
- 18-03-2015
- Concedì
- 16-03-2016
- Stritgà
- 23-12-2021
- Motiv
- Taxa annuala betg pajada
- Classas IPC
- B65D 83/04 (2006.01)B65D 83/06 (2006.01)
- Prioritad
- EP 12167791 11.05.2012
- Dumonda PCT
- PCT/EP2013/059691 09.05.2013
- Publicaziun PCT
- WO2013/167715 14.11.2013
- Lingua da l’annunzia
- englais
- Funtauna
- Swissreg
Istorgia
Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.
- 23-12-2021
Stritgà, taxa betg pajada
Published in Swissreg on 23.12.2021
- 16-05-2020
Represchentant inscrit
- Representative
- BOVARD AG, Patent- und Markenanwälte, Optingenstrasse 16, 3013 Bern
Published in Swissreg on 16.05.2020
- 16-05-2020
Transferì
- Owner
- Novartis AG, Lichtstrasse 35, 4056 Basel → Phillips-Medisize A/S, Gimsinglundvej 20, 7600 Struer, Denmark
Published in Swissreg on 16.05.2020
- 16-03-2016
Concedì
Published in Swissreg on 16.03.2016
Partidas
Inventur
Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.